Zota Health Care Ltd
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.[1]
- Market Cap ₹ 4,170 Cr.
- Current Price ₹ 1,204
- High / Low ₹ 1,740 / 917
- Stock P/E
- Book Value ₹ 200
- Dividend Yield 0.08 %
- ROCE -8.47 %
- ROE -15.0 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Stock is trading at 6.01 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -1.25%
- Company has a low return on equity of -19.9% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25 | 38 | 50 | 56 | 85 | 95 | 106 | 131 | 139 | 180 | 292 | 539 | |
| 21 | 33 | 43 | 47 | 77 | 90 | 105 | 116 | 132 | 173 | 298 | 520 | |
| Operating Profit | 4 | 5 | 6 | 8 | 8 | 5 | 1 | 15 | 7 | 8 | -6 | 19 |
| OPM % | 14% | 13% | 13% | 15% | 9% | 5% | 1% | 11% | 5% | 4% | -2% | 3% |
| 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | |
| Interest | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 5 | 11 | 17 |
| Depreciation | 0 | 1 | 1 | 2 | 1 | 2 | 3 | 4 | 12 | 20 | 43 | 82 |
| Profit before tax | 3 | 3 | 5 | 6 | 8 | 4 | -0 | 12 | -5 | -16 | -58 | -80 |
| Tax % | 34% | 33% | 33% | 33% | 29% | 29% | -41% | 28% | 23% | -11% | -2% | -7% |
| 2 | 2 | 3 | 4 | 6 | 3 | -0 | 9 | -6 | -14 | -57 | -74 | |
| EPS in Rs | 2.17 | 1.43 | 1.85 | 2.12 | 2.26 | 1.12 | -0.09 | 3.54 | -2.29 | -5.55 | -19.70 | -21.35 |
| Dividend Payout % | 0% | 50% | 38% | 34% | 32% | 90% | -1,170% | 42% | -44% | -18% | -5% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 57% |
| TTM: | 85% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 49% |
| 3 Years: | 58% |
| 1 Year: | 28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -16% |
| 3 Years: | -20% |
| Last Year: | -15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 10 | 12 | 14 | 18 | 25 | 25 | 25 | 25 | 26 | 29 | 35 |
| Reserves | 5 | 3 | 4 | 4 | 51 | 44 | 42 | 64 | 55 | 64 | 195 | 659 |
| 3 | 6 | 5 | 5 | 0 | 0 | 0 | 15 | 45 | 95 | 140 | 270 | |
| 5 | 10 | 14 | 17 | 21 | 20 | 19 | 35 | 33 | 43 | 76 | 167 | |
| Total Liabilities | 20 | 29 | 35 | 40 | 90 | 88 | 85 | 139 | 158 | 228 | 439 | 1,131 |
| 8 | 10 | 9 | 8 | 10 | 15 | 14 | 29 | 62 | 103 | 185 | 383 | |
| CWIP | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 3 | 5 | 6 | 2 |
| Investments | 0 | 0 | 0 | 0 | 16 | 14 | 10 | 33 | 8 | 5 | 54 | 264 |
| 12 | 19 | 26 | 32 | 63 | 59 | 61 | 77 | 85 | 116 | 193 | 483 | |
| Total Assets | 20 | 29 | 35 | 40 | 90 | 88 | 85 | 139 | 158 | 228 | 439 | 1,131 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 5 | -3 | 6 | -1 | 13 | -2 | -6 | -50 | -84 | |||
| -1 | -1 | 9 | -4 | 4 | -27 | 15 | -13 | -92 | -314 | |||
| -2 | -4 | -6 | -3 | -2 | 14 | -14 | 19 | 145 | 490 | |||
| Net Cash Flow | 0 | 0 | -1 | -1 | 1 | 1 | -1 | -0 | 3 | 92 | ||
| Free Cash Flow | 2 | 4 | -6 | -1 | -2 | 10 | -13 | -23 | -96 | -197 | ||
| CFO/OP | 78% | 81% | -12% | 147% | -134% | 115% | 2% | -59% | 811% | -394% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 71 | 79 | 77 | 95 | 112 | 99 | 102 | 73 | 55 | 51 | 50 |
| Inventory Days | 122 | 141 | 134 | 175 | 208 | 139 | 140 | 121 | 183 | 201 | 277 | 329 |
| Days Payable | 77 | 90 | 0 | 0 | 104 | 82 | 77 | 78 | 116 | 126 | 111 | 178 |
| Cash Conversion Cycle | 120 | 123 | 212 | 251 | 199 | 169 | 161 | 145 | 140 | 131 | 217 | 200 |
| Working Capital Days | 102 | 70 | 78 | 80 | 175 | 152 | 143 | 108 | 111 | 75 | 100 | 84 |
| ROCE % | 20% | 32% | 6% | -2% | 15% | -2% | -7% | -17% | -8% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Davaindia Stores Number |
|
||||||||
| Domestic Marketing Distributors Number |
|||||||||
| Davaindia COCO Stores Number |
|||||||||
| Davaindia Portfolio SKUs Number |
|||||||||
| Export Dossiers Registered Number |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
5 June 2026 - Zota Health Care will attend Nirmal Bang Securities Investor Conference on June 15, 2026.
-
Disclosure under SEBI Takeover Regulations
5 June 2026 - HIMANSHU Muktilal ZOTA has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the SEBI (Substantial Acquisition of Shares …
-
Analysts/Institutional Investor Meet/Con. Call Updates
29 May 2026 - Zota Health Care released Q4/FY26 earnings call transcript; FY26 revenue rose 83.86% to INR 538.65 crore, EBITDA positive.
-
Analysts/Institutional Investor Meet/Con. Call Updates
26 May 2026 - Zota Health Care to attend Axis Capital’s Rising Stars Conference on June 2, 2026 in Mumbai.
-
Analysts/Institutional Investor Meet/Con. Call Updates
25 May 2026 - Audio recording link shared for FY26 Q4 and annual earnings conference call.
Annual reports
Concalls
-
May 2026TranscriptPPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Oct 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT
-
Jul 2025TranscriptAI SummaryPPT
-
Jun 2025Transcript PPT
-
Apr 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Jun 2023TranscriptAI SummaryPPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022TranscriptAI SummaryPPT
-
Sep 2022TranscriptAI SummaryPPT
-
Jun 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Dec 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
Jun 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Dec 2020TranscriptAI SummaryPPT
-
Sep 2020TranscriptAI SummaryPPT
-
Jun 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
Business segments & Revenue 9MFY26[1][2]
A. Domestic sales (13%):[3] The company’s domestic marketing business(oldest vertical) is supported by a distribution network of 1,050+ distributors and a portfolio of 4,000+ products across multiple therapeutic segments. It sources formulations from domestic manufacturers, including those recognised by global health agencies, and distributes them across the country.